Cozzi, Mariano
Monteduro, Davide
Parrulli, Salvatore
Ristoldo, Federica
Corvi, Federico
Zicarelli, Federico
Staurenghi, Giovanni
Invernizzi, Alessandro http://orcid.org/0000-0003-3400-1987
Funding for this research was provided by:
Università degli Studi di Milano
Article History
Received: 17 May 2021
Revised: 29 July 2021
Accepted: 10 August 2021
First Online: 7 September 2021
Declarations
:
: The study was approved by the local institutional ethics committee (Comitato Etico Milano, Area 1).
: All subjects from this research read, signed, and gave the researcher their informed consent prior to their inclusion in the study.
: The corresponding author (Alessandro Invernizzi) had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
: MC, Nidek (R),CenterVue (R), Bayer (R); GS, Heidelberg, Optos, Centervue, Zeiss, Bayer (R); Heidelberg, Optos, Centervue, Apellis Pharmaceuticals, Allergan, Astrellas, Bayer, Boehringer Ingelheim, Genentech, Graybug, Novartis, Roche, Chengdu Kanghong Biotech, Kyoto Drug Discovery and Development, Biogen (C); Ocular Instruments (Patent holder); AI, Allergan (R), Novartis (C), Bayer (C). All the other authors declare no competing interests.